|
|
| | HO-PEG10-CH2COOH Basic information |
| Product Name: | HO-PEG10-CH2COOH | | Synonyms: | HO-PEG10-CH2COOH;32-Hydroxy-3,6,9,12,15,18,21,24,27,30-decaoxadotriacontan-1-oic acid;Hydroxy-PEG10-CH2COOH | | CAS: | 2250056-53-0 | | MF: | C22H44O13 | | MW: | 516.58 | | EINECS: | | | Product Categories: | | | Mol File: | 2250056-53-0.mol |  |
| | HO-PEG10-CH2COOH Chemical Properties |
| Boiling point | 604.7±50.0 °C(Predicted) | | density | 1.154±0.06 g/cm3(Predicted) | | pka | 3.39±0.10(Predicted) | | form | Oil | | color | Colorless to light yellow |
| | HO-PEG10-CH2COOH Usage And Synthesis |
| Uses | HO-PEG10-CH2COOH is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs[1]. | | Biological Activity | HO-PEG10-CH2COOH is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs[1].
PROTACs contain two different ligands connected by a linker; one is a ligand for an E3 ubiquitin ligase and the other is for the target protein. PROTACs exploit the intracellular ubiquitin-proteasome system to selectively degrade target proteins[1]. | | IC 50 | PEGs | | References | [1]. An S, et al. Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs. EBioMedicine. 2018 Oct;36:553-562 |
| | HO-PEG10-CH2COOH Preparation Products And Raw materials |
|